TRP Channels in the Focus of Trigeminal Nociceptor Sensitization Contributing to Primary Headaches

Pain in trigeminal areas is driven by nociceptive trigeminal afferents. Transduction molecules, among them the nonspecific cation channels transient receptor potential vanilloid 1 (TRPV1) and ankyrin 1 (TRPA1), which are activated by endogenous and exogenous ligands, are expressed by a significant p...

Teljes leírás

Elmentve itt :
Bibliográfiai részletek
Szerzők: Dux Mária
Rosta Judit
Messlinger Karl
Dokumentumtípus: Cikk
Megjelent: 2020
Sorozat:INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 21 No. 1
doi:10.3390/ijms21010342

mtmt:31134914
Online Access:http://publicatio.bibl.u-szeged.hu/18880
LEADER 02116nab a2200229 i 4500
001 publ18880
005 20200610121843.0
008 200610s2020 hu o 0|| zxx d
022 |a 1661-6596 
024 7 |a 10.3390/ijms21010342  |2 doi 
024 7 |a 31134914  |2 mtmt 
040 |a SZTE Publicatio Repozitórium  |b hun 
041 |a zxx 
100 1 |a Dux Mária 
245 1 0 |a TRP Channels in the Focus of Trigeminal Nociceptor Sensitization Contributing to Primary Headaches  |h [elektronikus dokumentum] /  |c  Dux Mária 
260 |c 2020 
300 |a Azonosíító: 342-Terjedelem: 23 p 
490 0 |a INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES  |v 21 No. 1 
520 3 |a Pain in trigeminal areas is driven by nociceptive trigeminal afferents. Transduction molecules, among them the nonspecific cation channels transient receptor potential vanilloid 1 (TRPV1) and ankyrin 1 (TRPA1), which are activated by endogenous and exogenous ligands, are expressed by a significant population of trigeminal nociceptors innervating meningeal tissues. Many of these nociceptors also contain vasoactive neuropeptides such as calcitonin gene-related peptide (CGRP) and substance P. Release of neuropeptides and other functional properties are frequently examined using the cell bodies of trigeminal neurons as models of their sensory endings. Pathophysiological conditions cause phosphorylation, increased expression and trafficking of transient receptor potential (TRP) channels, neuropeptides and other mediators, which accelerate activation of nociceptive pathways. Since nociceptor activation may be a significant pathophysiological mechanism involved in both peripheral and central sensitization of the trigeminal nociceptive pathway, its contribution to the pathophysiology of primary headaches is more than likely. Metabolic disorders and medication-induced painful states are frequently associated with TRP receptor activation and may increase the risk for primary headaches. 
700 0 1 |a Rosta Judit  |e aut 
700 0 1 |a Messlinger Karl  |e aut 
856 4 0 |u http://publicatio.bibl.u-szeged.hu/18880/1/DuxM_IntJMolSci_2020.pdf  |z Dokumentum-elérés